VYT — Vytrus Biotech SA Balance Sheet
0.000.00%
Last trade - 00:00
- €15.49m
- €16.46m
- €3.74m
- 69
- 20
- 38
- 34
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.829 | 1.09 | 1.28 | 0.725 | 1.11 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.163 | 0.214 | 0.265 | 0.531 | 0.782 |
Total Inventory | |||||
Total Current Assets | 1.16 | 1.54 | 1.82 | 1.68 | 2.45 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.491 | 0.575 | 0.678 | 1.03 | 0.93 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 5.24 | 6.21 | 7.18 | 8 | 9.31 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.458 | 0.643 | 0.806 | 1.27 | 0.996 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.8 | 2.6 | 2.93 | 3.25 | 4.02 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 3.44 | 3.61 | 4.25 | 4.75 | 5.29 |
Total Liabilities & Shareholders' Equity | 5.24 | 6.21 | 7.18 | 8 | 9.31 |
Total Common Shares Outstanding |